Skip to content

Comparison of the effect of Zinc and Vitamin D supplementation on Acute Bronchiolitis

Comparison of the effect of Zinc and Vitamin D supplementation on Acute Bronchiolitis in 2 to 23 months old children, a clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131217015835N7
Enrollment
135
Registered
2018-05-17
Start date
2017-09-27
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute bronchiolitis. Acute bronchiolitis, unspecified

Interventions

Intervention 1: Intervention group: First group takes 2 mg/kg/day(max 20 mg) syrup Zinc Sulfate10 of Alhavy Company for 1 week or during hospitalization if the days of admission are less than 1 week.

Sponsors

Chancellor of Research and Technology, Zanjan University of Medical Sciences (Primary sponsor)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Months to 23 Months

Inclusion criteria

Inclusion criteria: Age under 2 years old The first wheezing attack with respiratory infection Pulse Rate less than 180 Respiratory Rate less than 100

Exclusion criteria

Exclusion criteria: Use of supplementary more than routine Previous wheezing or use of bronchodilator Prematurity Cardiopulmonary disease Aspiration Neuromuscular disease Immune deficiency Need for mechanical ventilation Previous use of corticostroid in 2 last weeks Intolerancy or cuasing side effects after using the medicine

Design outcomes

Primary

MeasureTime frame
Wheezing. Timepoint: first day,third day,and seventh day in the hospital. Method of measurement: using stethoscope.;Respiratory rate. Timepoint: first day,third day,and seventh day in the hospital. Method of measurement: counting of chest movements.

Secondary

MeasureTime frame
The duration of staying in the hospital. Timepoint: first day,third day,seventh day. Method of measurement: counting the days of staying in the hospital.;The duration of fever. Timepoint: first day,third day,seventh day. Method of measurement: thermometer.;Percent of arterial saturation of oxygen. Timepoint: first day,third day,seventh day. Method of measurement: pulseoxymeter.;The duration of existence of cough. Timepoint: first day,third day.seventh day. Method of measurement: asking from the patient.;Side effects of drugs. Timepoint: first day,third day,seventh day. Method of measurement: asking from the patient and physical examination.;The duration of cyanosis. Timepoint: first day,third day,seventh day. Method of measurement: observe the color of skin.;The duration of respiratoty distress. Timepoint: first day,third day,seventh day. Method of measurement: observe useing of respiratory muscles which are not the main ones.;The duration of dehydration. Timepoint: first day,third day,seventh day. Method of measurement: amount of urine out put and mucusal dryness and skin turgor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Parisa Khoshnevis Asl

Zanjan University of Medical Sciences

khoshnevis@zums.ac.ir+98 24 3313 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026